PFE Technical Analysis
As of date:2/6/2023
PFE stock price:43.76
PFE 50 DMA:48.44
PFE 200 DMA:47.78
PFE MACD (200-50):-0.66
PFE RSI:30.47
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)30.47
Extremely
Oversold

Also see:
PFE Market Cap History
PFE Shares Outstanding History
PFE YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree PFE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Trupanion (TRUP) Shares Cross Below 200 DMA
1 hour, 20 minutes ago


CHS Breaks Below 200-Day Moving Average - Notable for CHSCM
1 hour, 20 minutes ago


NUVA Makes Notable Cross Below Critical Moving Average
1 hour, 23 minutes ago


PRTS Crosses Below Key Moving Average Level
1 hour, 23 minutes ago


Mesa Laboratories (MLAB) Shares Cross Below 200 DMA
1 hour, 30 minutes ago


Notable Two Hundred Day Moving Average Cross - ENFN
1 hour, 36 minutes ago


BlackRock Municipal Target Term Trust Breaks Below 200-Day Moving Average - Notable for BTT
1 hour, 43 minutes ago


First Trust Dorsey Wright Dynamic Focus 5 (FVC) Shares Cross Below 200 DMA
1 hour, 43 minutes ago


FCTR Crosses Below Key Moving Average Level
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - AVY
1 hour, 56 minutes ago


Cohen & Steers Total Return Realty Fund (RFI) Shares Cross Below 200 DMA
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - VBND
2 hours ago


Loblaw Companies (L.CA) Shares Cross Above 200 DMA
2 hours, 4 minutes ago


Sonos Inc Breaks Below 200-Day Moving Average - Notable for SONO
4 hours, 28 minutes ago


The Trade Desk Breaks Below 200-Day Moving Average - Notable for TTD
4 hours, 30 minutes ago


More Technical Analysis News

PFE Technical AnalysisPFE RSI
Pfizer is a research-based, global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Co. collaborates with healthcare providers, governments and local communities to support and expand access to healthcare around the world. Co. provides vaccines across various ages (infants, adolescents and adults) in pneumococcal disease, meningococcal disease, tick-borne encephalitis and novel coronavirus disease of 2019 (COVID-19). Key products include: Comirnaty/BNT162b2, the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba.

When researching a stock like Pfizer, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from PFE Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for PFE stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
PFE DMAPFE MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pfizer (PFE) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

PKI Technical Analysis
REGN Technical Analysis
RMD Technical Analysis
STE Technical Analysis
SYK Technical Analysis
TECH Technical Analysis
TFX Technical Analysis
TMO Technical Analysis
UHS Technical Analysis
VRTX Technical Analysis
More Healthcare companies »

 

PFE Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2023, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.